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In the past decade, Caenorhabditis elegans has been used to dissect several genetic pathways involved in immunity; however,
little is known about transcription factors that regulate the expression of immune effectors. C. elegans does not appear to have
a functional homolog of the key immune transcription factor NF-kB. Here we show that that the intestinal GATA transcription
factor ELT-2 is required for both immunity to Salmonella enterica and expression of a C-type lectin gene, clec-67, which is
expressed in the intestinal cells and is a good marker of S. enterica infection. We also found that ELT-2 is required for immunity
to Pseudomonas aeruginosa, Enterococcus faecalis, and Cryptococcus neoformans. Lack of immune inhibition by DAF-2, which
negatively regulates the FOXO transcription factor DAF-16, rescues the hypersusceptibility to pathogens phenotype of elt-
2(RNAi) animals. Our results indicate that ELT-2 is part of a multi-pathogen defense pathway that regulates innate immunity
independently of the DAF-2/DAF-16 signaling pathway.
Citation: Kerry S, TeKippe M, Gaddis NC, Aballay A (2006) GATA Transcription Factor Required for Immunity to Bacterial and Fungal Pathogens. PLoS
ONE 1(1): e77. doi:10.1371/journal.pone.0000077
INTRODUCTION
The study of innate immunity received renewed attention when
the first parallels between mammalian and Drosophila melanogaster
immunity were discovered (reviewed in [1–3]). Since then, various
invertebrate model systems have been used to dissect highly-
conserved immune responses without the complications of adaptive
immunity. The genetically tractable nematode Caenorhabditis
elegans, which has been used for decades to study the mechanisms
of a number biological processes, has become a well-established
invertebrate model for the study of microbial pathogenesis and
innate immunity (reviewed in [1,4–7]). C. elegans has evolved
mechanisms to recognize and respond to potential pathogens using
an inducible immune system that contains many highly-conserved
effectors, including anti-bacterial proteins, lysozymes, lipases, and
C-type lectins [8]. Additionally, conserved signaling pathways
have been linked to C. elegans immunity, including the CED-3,
TGF-b, PMK-1 MAP kinase, and DAF-2 pathways (reviewed in
[1,6,9]), suggesting that despite the vast evolutionary gulf between
nematodes and mammals, some of the underlying mechanisms of
immunity may be similar.
Despite the similarities, there are also characteristics of the
immune response of C. elegans that distinguish it from mammals
and other invertebrates. Although Toll receptors, first studied in
Drosophila melanogaster and subsequently studied in mammals, are
highly conserved across species, they do not appear to play a role
in C. elegans immune responses [10]. Specifically, the single
nematode Toll receptor homolog, Tol-1, is expressed in the
nematode nervous system and is involved in bacterial avoidance
behaviors, rather than in the activation of antimicrobial genes
[10,11]. Consistent with the lack of Toll-like receptor-mediated
immunity, there is no evidence of a NF-kB homolog in C. elegans.
NF-kB-like transcription factors are critical in the regulation of
Toll immune responses as they control the expression of key genes
involved in innate immunity in many organisms (recently reviewed
in [12]). Thus, there is a distinct need to determine exactly which
transcription factors are involved in modulating nematode
immune responses, some of which may also play important
immunity roles in mammals.
Recently, Shapira et al. [13] demonstrated that the intestinal
transcription factor ELT-2 regulates intestinal immunity to the
human pathogen P. aeruginosa. Here we show that disruption of
ELT-2 causes nematodes to become hypersusceptible to Salmonella
enterica-mediated killing and that ELT-2 upregulates the expression
of clec-67 which is a marker of S. enterica infection in C. elegans. Our
results also suggest that ELT-2 is part of a multi-pathogen defense
pathway that regulates innate immunity not only to S. enterica and
Pseudomonas aeruginosa, but also to the Gram-positive bacterium
Enterococcus faecalis and to the fungal pathogen Cryptococcus neofor-
mans. We also show that ELT-2 functions in C. elegans immunity
independently of the DAF-2/DAF-16 signaling pathway. These
data indicate that ELT-2 is an important regulator of a conserved
C. elegans immune response to pathogens.
RESULTS
elt-2 RNAi animals are hypersusceptible to
S. enterica-mediated killing
The digestive tract of C. elegans is a primary interface between
the immune system and potential bacterial pathogens. This is
especially important in the case of bacteria such as the human
pathogen S. enterica which is capable of establishing a persistent
infection in the C. elegans intestine [14,15]. In addition, several
known effectors of the C. elegans immune system are expressed in
the intestinal cells. Because of this link between the intestine and
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which might modulate C. elegans immune responses.
Over 900 functional transcription factors are predicted to be
encoded in the C. elegans genome [16]. To identify genes encoding
transcription factors involved in the regulation of immune effectors
expressed in the C. elegans intestinal cells, candidates were selected
based on the following criteria: i) genes known to be expressed in
the intestine (141 candidates), ii) genes expressed during adulthood
(10 of the 141 candidates), and iii) genes which only regulate
intestinal functions or for which a function in adulthood has not
been reported (7 of the 10 candidates). Of the seven candidates,
five were chosen for further analysis based on the availability of
RNAi clones [17]. Thus, to address whether the selected candidate
genes play a role in C. elegans immunity, we used RNAi to inhibit
their expression and tested the susceptibility of these gene ablated
animals to S. enterica. The results shown in Table 1 demonstrate
that only RNAi ablation of elt-2 results in consistent increased
susceptibility of C. elegans to S. enterica.
The increased susceptibility of elt-2(RNAi) animals to S. enterica
(Table 1 and Figure 1A) indicates that ELT-2 may be involved in
the regulation of an immune response to this pathogen. However,
it is also possible that elt-2(RNAi) animals are sickly due to
a malfunctioning intestine. ELT-2 is a crucial GATA transcription
factor involved in intestinal differentiation [18–22] and elt-2
knockouts exhibit a gut-obstructed (Gob) phenotype that results in
arrest at L1 stage larvae and subsequent death, apparently by
starvation [18]. Therefore, to study whether elt-2 ablation by
RNAi makes the animals sickly, we first assayed the life span of elt-
2 RNAi nematodes. Figure 1B shows that although elt-2 RNAi
animals exhibit a reduced life span compared to control animals,
they survive at least eight days, indicating that starvation is not
a cause of death.
To test whether elt-2(RNAi) animals are more susceptible to S.
enterica-mediated killing when taking into account their reduced life
span on E. coli, the relative mortality of elt-2(RNAi) animals feeding
on S. enterica was used to assess the susceptibility to S. enterica-
mediated killing of elt-2 RNAi animals. The relative mortality
measure takes into account changes in life span due to a general
modification in fitness rather than a specific defect in innate
immunity against S. enterica. The relative mortality of elt-2(RNAi)
animals was calculated as described in Materials and methods and
determined to be 2.4 (Table 2). The relative mortality obtained is
comparable to the relative mortality of animals lacking CED-3-
mediated immunity [23] and greater than the relative mortality of
animals lacking p38/PMK-1 [24], which is crucial for C. elegans
immunity [25–28], indicating that the shortened life span of the elt-
2(RNAi) animals infected by S. enterica is not simply a consequence
of being sickly.
Interestingly, within 24 hours, elt-2(RNAi) animals show dis-
tended intestines full of E. coli that clearly contrast with the non-
distended intestinal lumens of control animals (Figures 1C and
1D). This intestinal distension was not seen within 20 minutes of
exposure to E. coli expressing DSred (data not shown), which
indicates that intestinal distension of elt-2(RNAi) animals is caused
by proliferating E. coli rather than by an abnormal intestinal
structure. This is not surprising given that proliferating E. coli is
a cause of death in C. elegans [29], that E. coli grown on rich media
kills C. elegans [30], and that immunocompromised animals are
killedbyE.coli[31].Additionally,after24 hoursofexposuretoE.coli
expressing DSred, elt-2 RNAi animals exhibited intestinal coloniza-
tion by the bacteria; DSred fluorescence was present in the elt-2
RNAi nematode intestine even after three one-hour-transfers onto
fresh nonfluorescent E. coli plates (data not shown). This indicates
that E. coli expressing DSred is able to persistently colonize elt-2
RNAi animals, which is of interest as E. coli does not typically
colonize the nematode intestine in a persistent fashion [14].
To ensure that the intestinal distension and E. coli colonization
are not caused by an unseen blockage or an inability of the
intestinal muscles to move bacteria through the gut, the defecation
of elt-2(RNAi) nematodes exposed to E. coli was measured. As
shown in Figure 1E, defecation of elt-2(RNAi) animals is not
significantly different from vector control animals. Indeed, while
not significantly different, there is a consistent slight increase in the
defecation of elt-2(RNAi) animals. Taken together, these results
indicate that elt-2(RNAi) animals do not exhibit the Gob phenotype
observed in elt-2 knockouts, that they do not die by starvation, and
that they are immunocompromised animals killed by replicating
bacteria capable of colonizing their intestine.
ELT-2 controls expression of clec-67 which is
a marker of C. elegans immune response to S.
enterica
To provide further evidence of the role of ELT-2 in innate
immunity, we studied its involvement in the expression of the gene
clec-67, which encodes a C-type lectin. Traditionally, C-type lectins
function as soluble mediators that specifically bind carbohydrates,
resulting in pathogen clearance by opsonization. A recent report
shows that a C-type lectin encoding gene whose product possesses
antimicrobial activity is upregulated in Paneth cells by microbial
colonization, indicating that lectins are part of a primitive
mechanism of innate immunity [32]. In addition, genes encoding
C-type lectin domains have been found to be upregulated in C.
elegans by a human opportunistic pathogen [33], a nematode
specific pathogen [34], and a bacterial toxin [28], indicating that
they are conserved markers of C. elegans immunity.
We decided to use clec-67 as a marker of C. elegans immunity to
S. enterica because it is consistently upregulated by this pathogen in
several expression profiling experiments performed in our
laboratory, because it is expressed in the intestine (Figure 2A),
and because its promoter region contains a GATA binding site (A/
T GATA A/G). As shown in Figure 2B, the clec-67 upregulation
by S. enterica observed in our microarrays was confirmed by qRT-
PCR. Figure 2B also shows that when elt-2 expression is ablated by
RNAi, clec-67 is downregulated compared to vector control,
indicating that ELT-2 regulates the expression of this effector of C.
elegans immunity to S. enterica. To ensure that the differences in
expression pattern of clec-67 are not due to intestinal defects in elt-
2(RNAi) animals, we measured the expression of six intestinal
Table 1. ELT-2 is required for C. elegans immunity to S.
enterica.
......................................................................
RNAi treatment TD506SEM Events/Obs
a p-value vs control
control 5.9060.23 149/210
elt-2 1.9160.06 114/120 ,0.0001
F42G2.6 5.2460.22 97/120 0.1483
F23F12.9 5.5960.15 97/120 0.3375
ZK632.2 5.2860.19 93/120 0.1900
C18G1.2 5.6960.20 62/90 0.8779
Wild type nematodes grown on E. coli carrying a vector control or on E. coli
expressing double-stranded RNA of the gene listed in the RNAi treatment
column were exposed to S. enterica SL1344. TD506SEM and p-values were
calculated using PRISM as described in Experimental Procedures.
aAnimals that were not found or that died as a result of getting stuck to the wall
of the plate were censored.
doi:10.1371/journal.pone.0000077.t001
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PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e77housekeeping genes in elt-2(RNAi) and vector control nematodes
exposed to S. enterica (Figure 2C). The expression of each of these
genes is less than two-fold different from vector control, well within
the error range of the assay, and much less than the differences
seen in expression of clec-67. Therefore, the change in the
expression pattern of clec-67 is due to changes in ELT-2 levels, and
not to nonspecific changes in intestinal gene expression.
ELT-2 is required for proper C. elegans immunity to
a variety of microbial pathogens
To determine whether ELT-2 is part of an immune system specific
to S. enterica or whether it is required for immunity to pathogens in
general, elt-2(RNAi) animals were infected with the Gram-negative
bacterial pathogen P. aeruginosa [35], the Gram-positive bacterial
pathogen E. faecalis [30], and the fungal pathogen C. neoformans [36]
as described. For all of these pathogens, elt-2(RNAi) animals exhibit
increased mortality compared to vector control animals (Figure 3).
These data indicate that RNAi ablation of elt-2 increases C. elegans
susceptibility to different types of bacterial and fungal pathogens.
The DAF-2/DAF-16 insulin-like pathway which regulates
longevity in C. elegans has recently been linked to immunity against
bacteria. DAF-16 is a FOXO transcription factor, which regulates
a wide variety of genes required for longevity, stress-response,
development, and immunity [37,38], and it is negatively regulated
by DAF-2 [39]. Thus, daf-2 mutants exhibit higher DAF-16
activity and are more resistant to different bacterial pathogens
[31,40,41]. Because our data indicate that ELT-2 regulates a multi-
Figure 1. elt-2(RNAi) animals are hypersusceptible to S. enterica-mediated killing and are colonized by E. coli.( A) Wild-type nematodes grown on E.
coli carrying a vector control or on E. coli expressing elt-2 double-stranded RNA were exposed to S. enterica SL1344 (P,0.0001). 60 nematodes were
used for each condition. Results are representative of at least 3 independent experiments. (B) Wild-type nematodes grown on E. coli carrying a vector
control or on E. coli expressing elt-2 double-stranded RNA were placed on FUdR containing plates with lawns of heat-killed E. coli OP50 (P=0.0011).
20 nematodes were used for each condition. Results are representative of at least 3 independent experiments. (C) and (D) Wild-type nematodes
grown on E. coli carrying a vector control (C) or on E. coli expressing elt-2 double-stranded RNA (D) were exposed to E. coli expressing DSred for
24 hours, and then visualized using a Leica TCS SL spectral confocal microscope (bar=50 mm). (E) Wild-type nematodes grown on E. coli carrying
a vector control or on E. coli expressing elt-2 double-stranded RNA were transferred to a clean LB plate either immediately or after 24 hours exposure
to E. coli OP50 (+24 hrs), where they were allowed to defecate for 2 hours. Plates then were placed at 37uC overnight and colonies counted. The
combined data from 10 individual animals are shown, and data were normalized to the median colony count for the vector control at each timepoint.
Error bars represent SEM. Results are representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0000077.g001
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factor is required for the effects of DAF-2 in immunity to
pathogens. First, we studied whether daf-2(e1370) mutants were
more resistant to the fungal pathogen Cryptococcus neoformans and
then whether RNAi ablation of elt-2 reduces the resistance
phenotype of daf-2(e1370) animals. As shown in Figure 4, daf-
2(e1370) mutants are more resistant not only to S. enterica and E.
faecalis, as previously shown [40], but also to Cryptococcus neoformans,
indicating that DAF-2 regulates immune response to pathogens in
general. Furthermore, this increased resistance to C. neoformans is
dependent upon DAF-16 function as daf-2(e1370);daf-16(RNAi)
nematodes have increased mortality when compared to daf-
2(e1370) mutants (Figure 4D).
To address whether the DAF-2 pathway regulates the immune
system of the nematode via ELT-2, RNAi was used to ablate elt-2
in daf-2(e1370) animals which were then exposed to S. enterica, E.
faecalis, and C. neoformans. Visibly, the daf-2(e1370);elt-2(RNAi)
nematodes appear similar to elt-2(RNAi) animals, being thinner,
and more transparent than wild-type nematodes or daf-2(e1370)
mutants. However, the daf-2(e1370); elt-2(RNAi) nematodes are
significantly more resistant to all pathogens tested than elt-2 RNAi
Table 2. Relative Mortality of elt-2 RNAi animals on S. enterica.
......................................................................
Bacteria
RNAi
treatment Experiment TD506SEM Events/Obs
a
S. enterica control 1
b 6.1160.24 26/60
elt-2 2.0660.17 40/60
control 2 8.9960.35 9/20
elt-2 2.5360.22 16/20
control 3 7.4660.38 5/20
elt-2 3.9860.36 12/20
control 4 6.6760.25 30/60
elt-2 1.9760.08 50/60
control 5 5.1260.15 42/60
elt-2 2.8160.09 46/60
control 6 7.1760.27 20/40
elt-2 1.1060.27 32/40
control 7 6.2060.09 98/120
elt-2 0.8260.12 56/60
E. coli control 1
c 13.4860.15 16/20
elt-2 10.2560.16 19/20
control 2 15.3360.35 6/20
elt-2 10.9660.16 18/20
control 3 12.1560.13 13/20
elt-2 8.0360.23 13/20
Bacteria RNAi
treatment
Mean6SD
S. enterica control 6.8261.14
S. enterica elt-2 2.1760.99
E. coli control 13.6561.30
E. coli elt-2 9.7561.25
Relative Mortality=2.24
Wild type nematodes grown on E. coli carrying a vector control or on E. coli
expressing elt-2 double-stranded RNA were exposed to S. enterica SL1344 or E.
coli OP50 on plates containing FUdR. TD50 and SEM were calculated as
described in Experimental Procedures. Relative mortality is determined by the
following equation: (TD50 of control worms on S. enterica/TD50 of elt-2 RNAi
worms on S. enterica)/( TD50 of control worms on E. coli/mean TD50 of elt-2 RNAi
worms on E. coli).
aAnimals that were not found or that died as a result of getting stuck to the wall
of the plate were censored.
bIndicates experiment depicted in Figure 1A.
cIndicates experiment depicted in Figure 1B.
doi:10.1371/journal.pone.0000077.t002
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Figure 2. Expression of clec-67 is controlled by ELT-2. (A) Pclec-67::gfp
nematodes were grown on E. coli OP50 and were visualized using
a Leica MZ FLIII fluorescence stereomicroscope. (B) Microarray (white)
and qRT-PCR (light grey) comparing expression of clec-67 in wild-type
nematodes grown on S. enterica SL1344 versus wild-type nematodes
grown on E. coli OP50. qRT-PCR comparing expression of clec-67 in wild-
type nematodes grown on E. coli carrying a vector control versus wild-
type nematodes grown on E. coli expressing elt-2 double-stranded RNA
(dark grey). Results are the average of 3-7 independent experiments.
Error bars represent SEM. (C) qRT-PCR comparing expression of a variety
of intestinal housekeeping genes in wild-type nematodes grown on E.
coli carrying a vector control versus wild-type nematodes grown on E.
coli expressing elt-2 double-stranded RNA. Results are the average of 5
independent experiments. Error bars represent SEM.
doi:10.1371/journal.pone.0000077.g002
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PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e77animals (Figure 4). Interestingly, daf-2(e1370); elt-2(RNAi) animals
have increased resistance to E. faecalis compared to daf-2(e1370)
animals, indicating that ELT-2 may suppress immune defenses
specific to E. faecalis that are typically inhibited by DAF-2. Control
experiments indicate that daf-2(e1370);daf-16(RNAi) animals have
increased susceptibility to all pathogens when compared to daf-
2(e1370) (Figure 4D and data not shown).
DISCUSSION
Our results suggest that the GATA transcription factor ELT-2
regulates a C. elegans innate immunity independently of DAF-2/
DAF-16 and that it regulates the expression of clec-67 which is
a marker of C. elegans immunity to S. enterica infection. Previously,
ELT-2 had been linked to intestinal development, but its role in
innate immunity was unknown. Since DAF-16 does not appear to
be required for immunity to bacterial [40] and fungal pathogens
(Figure 4C), the ELT-2 requirement for proper immunity to
bacterial and fungal pathogens described here provides one of the
first direct evidences indicating that a C. elegans transcription factor
is required not only for the expression of immunity-related genes
but also for survival in the presence of pathogens. Consistent with
our results, a paper published while this manuscript was being
prepared indicates that ELT-2 is required for immunity to
Pseudomonas aeruginosa [13].
The most well-known mammalian GATA transcription factor is
GATA-3, which regulates the development of CD4+ T cells to
a Th2 phenotype [42]. However, since C. elegans does not have
adaptive immunity, our data indicate that GATA transcription
factors are also involved in innate immune responses. This is
supported by other invertebrate models, where GATA binding
elements have been found in the promoters of genes important in
defense responses of D. melanogaster [43–45], the silkworm Bombyx
mori [46], and the mosquito Aedes aegypti [47]. GATA transcription
factors are evolutionarily conserved in a wide variety of eukaryotes
and are most often involved in cellular development and
differentiation [48]. Human GATAs 4–6, which are the most
similar to C. elegans ELT-2, are involved in development of gut and
cardiac tissue. Additionally, human GATA-4 has been shown to
regulate cardiac stress responses [49–51], indicating that GATA-4
may have more than a developmental role in mammals.
Since C. elegans does not appear to have functional NF-kB-like
transcription factors, ELT-2 may be an ancestral transcription
factor required for surviving microbial infections in a common
ancestor of nematodes and vertebrates. The only other C. elegans
transcription factor, DAF-16, known to regulate the expression of
classical immune effectors, is not required for defense to bacterial
pathogens. We show here that like DAF-16, ELT-2 appears to
regulate the expression of immune effectors. In addition, it seems
to be required for survival in the presence of Gram-negative
bacteria, Gram-positive bacteria, and fungal pathogens. Lack of
immune inhibition by DAF-2 rescues, fully or partially, the
hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals
suggesting both that elt-2(RNAi) animals do not have developmen-
tal defects that make them more susceptible to pathogens and that
ELT-2 acts upstream or independently of the DAF-2/DAF-16
pathway. The facts that RNAi ablation of ELT-2 results in an
increased susceptibility to pathogens and that RNAi ablation of
DAF-16 (Figure 4) or mutations in daf-16 [40] does not affect the
susceptibility to pathogens argue in favor of the second possibility.
Takentogether,ourresultsindicate that DAF-16and ELT-2are two
key transcription factors that regulate two independent pathways
required for C. elegans innate immunity to microbial pathogens.
MATERIALS AND METHODS
Microbial and nematode strains
The following strains were used: Escherichia coli OP50 [52], Salmonella
enterica serovar typhimurium SL1344 [53], Enterococcus faecalis OG1RF
[54],CryptococcusneoformansH99[55],andPseudomonasaeruginosaPA14
[35]. C. elegans strains utilized were wild-type N2 and daf-2(e1370).
These strains were originally obtained from the Caenorhabditis
Genetics Center and maintained in our laboratory.
Figure 3. elt-2(RNAi) animals are more susceptible than wild-type
nematodes to a variety of pathogens. (A)Wild-type nematodes grown
on E. coli carrying a vector control or on E. coli expressing elt-2 double-
stranded RNA were exposed to P. aeruginosa PA14 (P=0.0001). (B) Wild-
type nematodes grown on E. coli carrying a vector control or on E. coli
expressing elt-2 double-stranded RNA were exposed to E. faecalis
OG1RF (P,0.0001). (C) Wild-type nematodes grown on E. coli carrying
a vector control or on E. coli expressing elt-2 double-stranded RNA were
exposed to C. neoformans H99 (P,0.0001). 60–120 nematodes were
used for each condition. Results are representative of at least 3
independent experiments.
doi:10.1371/journal.pone.0000077.g003
ELT-2 in Innate Immunity
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To generate the Pclec-67::gfp construct, the genomic region 520 to
20 bp upstream of clec-67 was PCR amplified using the follow-
ing primers generated by PCR Primer Design for C. elegans
promoter::gfp fusions (http://elegans.bcgsc.bc.ca/promoter_
primers/): TCGTTTCTAATGCTCTCGGAA and TGGGT-
CCTTTGGCCAATCCCGGGGCGTTTTATGCGGGTTTG-
TTTA. The gfp sequence was amplified from pPD95.79 (Addgene,
Cambridge, MA) by PCR with the following primers: CCCG-
GGATTGGCCAAAGGACCCAAAG and CCGCTTACAGA-
CAAGCTGTGACCG. These PCR products were mixed and an
additional PCR with the outside primers was performed to fuse the
promoter and gfp sequences. The linear PCR product of this
reaction was injected at 10 ng/ml into N2 animals to create the
transgenic line. The coinjection marker pRF4 was injected at
50 ng/ml. Transgenic animals were anesthetized with 10% sodium
azide solution and visualized using a Leica MZ FLIII fluorescence
stereomicroscope.
C. elegans killing assays
C. elegans wild-type N2 animals and daf-2 mutants were maintained
as hermaphrodites at 15uC, grown on modified NG agar plates
and fed with E. coli strain OP50 as described [52]. Cultures were
grown in Luria-Bertani (LB) broth and agar plates, except C.
neoformans H99 and E. faecalis OG1RF which were grown in yeast
peptone dextrose (YPD) and brain-heart infusion (BHI) medium,
respectively. All pathogens were grown at 37uC except C.
neoformans which was grown at 30uC. Pathogen lawns used for C.
Figure 4. The daf-2(e1370) mutation rescues the increased susceptibility to pathogens phenotype of elt-2(RNAi) animals. (A) Wild-type and daf2(e1370)
nematodes grown on E. coli carrying a vector control or on E. coli expressing elt-2 double-stranded RNA were exposed to S. enterica SL1344.
Significant differences were found when wild-type was compared to daf-2(e1370) (P,0.0001), when elt-2(RNAi) was compared to daf-2(e1370);elt-
2(RNAi) (P,0.0001), and when daf-2(e1370) was compared to daf-2(e1370);elt-2(RNAi) (P,0.0001). (B) Wild-type and daf2(e1370) nematodes grown on
E. coli carrying a vector control or on E. coli expressing elt-2 double-stranded RNA were exposed to E. faecalis OG1RF. Significant differences were
found when wild-type was compared to daf-2(e1370) (P=0.0056), when elt-2(RNAi) was compared to daf-2(e1370);elt-2(RNAi) (P,0.0001), and when
daf-2(e1370) was compared to daf-2(e1370);elt-2(RNAi) (P,0.0001). (C) Wild-type and daf2(e1370) nematodes grown on E. coli carrying a vector control
or on E. coli expressing elt-2 double-stranded RNA were exposed to C. neoformans H99 (P,0.0001). Significant differences were found when wild-type
was compared to daf-2(e1370) (P=0.0174) and when elt-2(RNAi) was compared to daf-2(e1370);elt-2(RNAi) (P,0.0001). No significant difference was
found when daf-2(e1370) was compared to daf-2(e1370);elt-2(RNAi) (P=0.1666). (D) Wild-type and daf2(e1370) nematodes grown on E. coli carrying
a vector control or on E. coli expressing daf-16 double-stranded RNA were exposed to C. neoformans H99. A significant difference was found when
daf-2(e1370) was compared to daf-2(e1370);daf-16(RNAi) (P,0.0001), but no significant difference was found when wild-type was compared to daf-
16(RNAi) (P=0.9375). 60-240 nematodes were used for each condition. Results are representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0000077.g004
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overnight culture of the bacterial strains on modified NG agar
medium (0.35% peptone) in 3.5 cm diameter Petri plates. C.
neoformans and E. faecalis were plated on BHI with 50 mg/ml
gentamycin selection. Plates were incubated overnight before
seeding them with young adult RNAi animals, created as
described above. The killing assays were performed at 25uC and
animals were transferred once a day to fresh plates, until no more
progeny were evident. Animals were scored at the times indicated
and considered dead upon failure to respond to touch.
C. elegans defecation assays
RNAi animals were transferred individually either directly from
RNAi plates (time 0) or after 24 hours of exposure to E. coli OP50
on modified NGM plates with 0.35% peptone. Animals were
initially individually transferred to clean LB agar plates for
10 minutes to remove excess bacteria, then transferred to a new
LB agar plate and allowed to defecate for 2 hours at 25uC.
Animals were then removed, and the plates incubated overnight at
37uC. Amount of defecation was determined by counting colonies
of E. coli on each plate. Data were normalized to the median
colony count of vector control for each experiment.
C. elegans aging assays
Modified NGM plates containing 0.35% peptone and 100 mg/ml
5-fluorodeoxyuridine FUdR [56] were plated with E. coli OP50
lawns and allowed to incubate at 37uC overnight. Young adult
RNAi animals were seeded onto these plates, and scored as
indicated for C. elegans killing assays. As FUdR inhibits growth of
progeny, daily transfer of nematodes was unnecessary.
RNA interference
We used RNA interference to generate loss-of-function RNAi
phenotypes by feeding worms with E. coli strain HT115(DE3)
expressing double-stranded RNA that is homologous to a target
gene [57,58]. Briefly, E. coli harboring the appropriate vectors
were grown in LB broth containing ampicillin (100 mg/ml) and
tetracycline (10 mg/ml) at 37uC overnight. Bacteria were plated
onto NGM plates containing 100 mg/ml ampicillin and 10 mM
Isopropyl b-D-thiogalactoside (IPTG) to induce double-stranded
RNA expression, and were allowed to grow overnight at 37uC.
Gravid adults were allowed to lay eggs on RNAi-expressing
lawns of bacteria for 6-12 hours. The eggs were allowed to develop
into young adults on RNAi or vector control plates at 25uCo ra t
15uC in experiments involving daf-2(e1370). Unc-22 RNAi was
used as a positive control for the creation of loss-of-function
phenotypes. Bacterial strains expressing double-stranded RNA to
inactivate the C. elegans genes have been described [17]. The clone
identity was confirmed by sequencing. RNAi-mediated ablation of
elt-2 results in animals that despite being typically smaller and
thinner than control counterparts, do survive to adulthood and do
not die by starvation (Figure 1B).
Statistical analyses
Animal survival was plotted as a staircase curve using the PRISM
(version 4.00) computer program. Survival curves are considered
significantly different than the control when P values are ,0.05.
Prism uses the product limit or Kaplan-Meier method to calculate
survival fractions and the logrank test, which is equivalent to the
Mantel-Heanszel test, to compare survival curves. The time for
50% of the nematodes to die (time to death 50, TD50) was
calculated using Prism software (version 4.01) using a non-linear
regression analysis of survival proportions utilizing the equation:
Y=Bottom+(Top-Bottom)/(1+10
(LogEC
50
-X)*Hill Slope)), where Top
is set at 100, Bottom is set at 0, X is the time in days and Y is the
percentage of nematodes alive at time X. In this instance, TD50 is
equivalent to EC50. The relative mortality of elt-2 RNAi animals
was calculated using the equation: (TD50 of control worms on S.
enterica/TD50 of elt-2 RNAi worms on S. enterica)/(TD50 control
worms on E. coli/TD50 of elt-2 RNAi on E. coli).
Confocal microscopy
Modified NGM plates with 0.35% peptone were plated with
overnight cultures of E. coli OP50 carrying the pDSred Express
plasmid (Invitrogen) and allowed to incubate overnight. Vector
control or elt-2 RNAi young adult nematodes were seeded onto
these plates and allowed to feed at 25uC. At the times indicated,
the animals were removed from the plates and placed on
microscope slides with 2% agarose pads in 10% sodium azide
solution. A coverslip was placed on top of the agar pad, and sealed
with clear nail polish. Images were captured at the indicated
magnifications using a Leica TCS SL confocal microscope and
Leica Confocal software (version 2.61 Build 1537) (Leica
Microsystems Heidelberg GmbH). Images were resized and
adjusted for brightness and contrast in Adobe Photoshop.
RNA isolation
Gravid adult N2 nematodes were lysed using a solution of sodium
hydroxide and bleach, washed, and the eggs synchronized
overnight in S basal liquid medium at room temperature.
Synchronized L1 animals were seeded onto modified NGM plates
with 0.35% peptone containing S. enterica or E. coli OP50, and
incubated at 25uC until the nematodes attained young adult stage
(approximately 24–30 hours). The animals were then collected by
washing the plates with M9 buffer, and RNA extracted using
Trizol reagent. Samples were further purified using a QIAGEN
RNeasy kit and residual genomic DNA removed using DNase
treatment (DNA-free kit Ambion Inc Austin TX). RNA concen-
tration was determined by spectrophotometer and samples were
diluted to 10ng/ul in RNase free water. A minimum of two
individual RNA isolations was performed for each experiment.
Quantitative Real-time PCR (qRT-PCR)
qRT-PCR was conducted using the Applied Biosystems Taqman
One-Step Real-time PCR protocol using SYBR Green fluores-
cence (Applied Biosystems) on an Applied Biosystems 7900HT
real-time PCR machine in 96 well plate format. Primers were
designed using Aceprimer version 1.2 (http://elegans.bcgsc.bc.ca/
aceprimer/aceprimer.shtml). Each independent RNA preparation
was measured at least twice by qRT-PCR. Within each experi-
ment, a minimum of duplicate wells was run for every primer set.
The data for each gene were normalized to the housekeeping
gene, ama-1, the large subunit of C. elegans RNA polymerase II.
Once normalized, the fold difference between SL1344 and OP50
samples was determined and plotted using PRISM.
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